Variable | P-value | Hazard ratio |
---|---|---|
TLG | 0.021 | |
Lower tertile | Reference | |
Middle tertile | 1.09 (0.58–2.04) | |
Upper tertile | 2.19 (1.17–4.07) | |
ER/PR and HER2 | <0.011 | |
ER or PR+, HER2− | Reference | |
HER2+ | 0.89 (0.47–1.70) | |
Triple-negative | 2.65 (1.43–4.92) | |
Grade (Grade 2 vs. 3) | 0.08 | 1.73 (0.93–3.22) |
Histology | 0.44 | |
Ductal | Reference | |
Lobular | 0.57 (0.17–1.88) | |
Other | 1.43 (0.59–3.46) | |
Visceral metastases (+ vs. −) | <0.011 | 2.14 (1.27–3.58) |
Hazard ratios (HR) are reported as estimate (95% confidence interval). TLG, total lesion glycolysis; ER, estrogen receptor; PR, progesterone receptor; HER2, human epidermal growth factor receptor 2.
Indicates statistically significant values.